Literature DB >> 33118647

Bone From Blood: Characteristics and Clinical Implications of Circulating Osteogenic Progenitor (COP) Cells.

Jack Feehan1,2, Moustapha Kassem3,4, Robert J Pignolo5, Gustavo Duque1,2.   

Abstract

Circulating osteogenic progenitor (COP) cells are a population of cells in the peripheral blood with the capacity for bone formation, as well as broader differentiation into mesoderm-like cells in vitro. Although some of their biological characteristics are documented in vitro, their role in diseases of the musculoskeletal system remains yet to be fully evaluated. In this review, we provide an overview of the role of COP cells in a number of physiological and pathological conditions, as well as identify areas for future research. In addition, we suggest possible areas for clinical utilization in the management of musculoskeletal diseases.
© 2020 American Society for Bone and Mineral Research (ASBMR). © 2020 American Society for Bone and Mineral Research (ASBMR).

Entities:  

Keywords:  CIRCULATING OSTEOGENIC PRECURSOR CELLS; COP CELLS; FRACTURE; FRAILTY; HETEROTOPIC OSSIFICATION; OSTEOPOROSIS; VASCULAR CALCIFICATION

Year:  2020        PMID: 33118647     DOI: 10.1002/jbmr.4204

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  3 in total

1.  A brief history of the development of stromal stem cells (stem cells of the skeleton).

Authors:  James T Triffitt
Journal:  Biomater Transl       Date:  2021-12-28

2.  Circulating Osteogenic Progenitor Cells Enhanced with Teriparatide or Denosumab Treatment.

Authors:  Mercè Giner; María Angeles Vázquez-Gámez; María José Miranda; Jesús Bocio-Nuñez; Francisco Jesús Olmo-Montes; Miguel Angel Rico; Miguel Angel Colmenero; María-José Montoya-García
Journal:  J Clin Med       Date:  2022-08-14       Impact factor: 4.964

3.  Circulating osteogenic progenitors and osteoclast precursors are associated with long-term glycemic control, sex steroids, and visceral adipose tissue in men with type 2 diabetes mellitus.

Authors:  Elliot Ballato; Fnu Deepika; Mia Prado; Vittoria Russo; Virginia Fuenmayor; Siresha Bathina; Dennis T Villareal; Clifford Qualls; Reina Armamento-Villareal
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-12       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.